News | October 31, 2023
Sun Pharma to co-market Zydus’s CKD treatment drug ‘Desidustat’ in India
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The initiative will focus on advocating for cleaner air
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
Commenced operations in flood-affected Himachal Pradesh
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Subscribe To Our Newsletter & Stay Updated
